Gene · 1763
Papers1,643
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,643
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel flower-shaped Ag@ZIF-67 chemiluminescence sensor for sensitive detection of CEA. | Talanta | 2023 | 36150338 | PubTator, text mining | PubMed |
| HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma. | Hepatology | 2023 | 35908246 | PubTator, text mining | PubMed |
| Okazaki fragment maturation: DNA flap dynamics for cell proliferation and survival. | Trends Cell Biol | 2023 | 35879148 | PubTator, text mining | PubMed |
| DNA Damage Response-Associated Cell Cycle Re-Entry and Neuronal Senescence in Brain Aging and Alzheimer's Disease. | J Alzheimers Dis | 2023 | 35848025 | PubTator, text mining | PubMed |
| Roles of homologous recombination in response to ionizing radiation-induced DNA damage. | Int J Radiat Biol | 2023 | 34283012 | PubTator, text mining | PubMed |
| Demethylase FTO inhibits the development of prostate cancer by upregulating EGR2 expression in an m6A manner. | Turk J Biol | 2022 | 37529797 | PubTator, text mining | PubMed |
| COVID-19 inhibits spermatogenesis in the testes by inducing cellular senescence. | Front Genet | 2022 | 36685935 | PubTator, text mining | PubMed |
| An original cuproptosis-related genes signature effectively influences the prognosis and immune status of head and neck squamous cell carcinoma. | Front Genet | 2022 | 36685880 | PubTator, text mining | PubMed |
| The role of SWI/SNF chromatin remodelers in the repair of DNA double strand breaks and cancer therapy. | Front Cell Dev Biol | 2022 | 36605718 | PubTator, text mining | PubMed |
| The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance. | Front Immunol | 2022 | 36569948 | PubTator, text mining | PubMed |
| Mechanisms of PARP1 inhibitor resistance and their implications for cancer treatment. | NAR Cancer | 2022 | 36568963 | PubTator, text mining | PubMed |
| Targeting the DNA Damage Response Machinery for Lung Cancer Treatment. | Pharmaceuticals (Basel) | 2022 | 36558926 | PubTator, text mining | PubMed |
| 53BP1: Keeping It under Control, Even at a Distance from DNA Damage. | Genes (Basel) | 2022 | 36553657 | PubTator, text mining | PubMed |
| Construction of an aflatoxin aptamer sensor based on a DNA nanoprism structure. | RSC Adv | 2022 | 36545084 | PubTator, text mining | PubMed |
| 3D CRISPR screen in prostate cancer cells reveals PARP inhibitor sensitization through TBL1XR1-SMC3 interaction. | Front Oncol | 2022 | 36523978 | PubTator, text mining | PubMed |
| Modulation of the Inflammatory Response in Polycystic Ovary Syndrome (PCOS)-Searching for Epigenetic Factors. | Int J Mol Sci | 2022 | 36498989 | PubTator, text mining | PubMed |
| RAD18 opposes transcription-associated genome instability through FANCD2 recruitment. | PLoS Genet | 2022 | 36480547 | PubTator, text mining | PubMed |
| CCAR2 functions downstream of the Shieldin complex to promote double-strand break end-joining. | Proc Natl Acad Sci U S A | 2022 | 36442094 | PubTator, text mining | PubMed |
| The Role of DNA Damage and Repair in Idiopathic Pulmonary Fibrosis. | Antioxidants (Basel) | 2022 | 36421478 | PubTator, text mining | PubMed |
| A rapid multiplex cell-free assay on biochip to evaluate functional aspects of double-strand break repair. | Sci Rep | 2022 | 36414637 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1763/papers?page=14